anx_I__cpt_7__cpt_2__cpt_2__table_1__row_6

Regulation (EU) No 536/2014 of the European Parliament and of the Council of 16 April 2014 on clinical trials on medicinal products for human use, and repealing Directive 2001/20/EC Text with EEA relevance · European Union

Another pharmaceutical form or strength of the investigational medicinal product is authorised or has a marketing authorisation in an ICH country and the investigational medicinal product is supplied by the marketing authorisation holder SmPC+P+A Yes Yes

← anx_I__cpt_7__cpt_2__cpt_2__table_1__row_5__cell_4 · All articles · anx_I__cpt_7__cpt_2__cpt_2__table_1__row_6__cell_1 →

Source: EUR-Lex (Cellar) · retrieved 2026-11-06 · Text as adopted (Official Journal); later amendments are not incorporated in this text.